Aquestive Therapeutics, Inc. - Common Stock — estadísticas financieras (NASDAQ:AQST) | MetaTrader

Ver el calendario completo Full chart

Noticias

Citizens reitera su calificación de Aquestive por el avance de Anaphylm

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Aquestive Therapeutics (AQST) Reports Q1 Loss, Beats Revenue Estimates

Aquestive Therapeutics supera por 0,06$ las previsiones de BPA en el primer trimestre del año

Aquestive obtiene una línea de deuda de 150 millones de dólares con Oaktree

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates

Will Journey Medical Corporation (DERM) Report Negative Q1 Earnings? What You Should Know

Will Aquestive Therapeutics (AQST) Report Negative Q1 Earnings? What You Should Know

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Aquestive reafirma la nueva presentación de la NDA para Anaphylm en el tercer trimestre de 2026

Aquestive nombra a Thomas Zalewski como director legal

Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST)